How many institutions own TSBX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TSBX shares is 26, representing 51.49% of the company's common stock.

Who are the major shareholders selling Turnstone Biologics Corp. stock?

BLACKROCK, INC., in the last quarter, reduced its stake in TSBX by -97.49% restricting it's holding to 1.07 thousand shares of worth nearly $383.00. JPMORGAN CHASE & CO also lessened -19.39% of the TSBX shares from its portfolio, reducing its holding to 158 shares of worth $57.00. ACADIAN ASSET MANAGEMENT LLC also shunned TSBX shares holding by -7.87% last quarter which brought its holding to 16.43 thousand shares worth $4.00K.

Investors who are buying TSBX stock?

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in TSBX by 100% in the last quarter. The institutional holder raised its holding to 208.89 thousand shares having worth more than $74.99K. XTX TOPCO LTD also added 5.72% more shares of TSBX to its portfolio, raising its holding to 37.79 thousand shares of worth $13.57K. RENAISSANCE TECHNOLOGIES LLC also increased its TSBX shares holding by 17.16% which brought its holding to 47.1 thousand shares worth $16.91K.

TSBX's major insiders: who are they?

The insider with the most stakes in TSBX is ORBIMED ADVISORS LLC , at the company. Additionally, TSBX stock is highly held by 10 percent owner Versant Ventures V, LLC and N/A N/A among others.

Did an insider recently sell TSBX stock?

Company executives, directors, and other insiders own 7.7% percent of Turnstone Biologics Corp.'s stock. Within the last six months, there have been 0 transaction(s) in which TSBX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased TSBX stock?

There have been 0 transaction(s) during the past 6-months in which Turnstone Biologics Corp. insiders have bought stock, totalling 0 shares

How much of TSBX does insiders own?

Around 0 Turnstone Biologics Corp. shares are held by insiders, which represents about 7.7% of TSBX stock.

Who is the insider with the largest stake?

TSBX , ORBIMED ADVISORS LLC holds the largest portfolio of the company's shares. TSBX shares owned by ORBIMED total nearly 3.1 million.

Which institution holds the most shares in TSBX?

CITADEL ADVISORS LLC is the largest institutional owner in TSBX which holds 208.89 thousand shares worth $74.99K or 0.9% of the total TSBX shares outstanding followed by BLACKROCK, INC. with ownership of 1.07 thousand shares representing 0% of the TSBX ownership. JPMORGAN CHASE & CO is the third largest stakeholder with 158 shares or 0% of the ownership worth more than $57.00.

Is Turnstone Biologics Corp. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TSBX is concerned, it is a stock which is not optionable.

Is there a short position on TSBX's shares?

Number of TSBX shares short is 378.12K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding TSBX shares are there?

As of today, 23.14M shares of TSBX are outstanding.

Is there many float in TSBX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TSBX has 14.05M shares in float.

TSBX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TSBX is 3.79.

Turnstone Biologics (TSBX) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares1.63

Short Percent Of Float3.29

Shares Outstanding23.14M

Shares Float14.05M

Shares Short378.12K

Short Ratio3.79

3.29%

Short % of Float

1.63%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

7.7% Percentage of Shares held by All Insiders

51.49% Percentage of Shares held by All Institutions

55.79% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 51.49% of TSBX shares are held by financial institutions. CITADEL ADVISORS LLC is the top corporate investor, holding 208.89K shares valued at $74.99K. A 0.9% stake in Turnstone Biologics Corp. is owned by the company. BLACKROCK, INC. owns 1.07K shares valued at $383.00, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2025	CITADEL ADVISORS LLC	0.9%	208.89K	74.99K	208.89K	+100.00%
Jun 30, 2025	BLACKROCK, INC.	0%	1.07K	383	-41.33K	-97.49%
Jun 30, 2025	JPMORGAN CHASE & CO	0%	158	57	-38	-19.39%
Jun 30, 2025	TAKEDA PHARMACEUTICAL CO LTD	3.87%	895.82K	321.6K	0	0
Jun 30, 2025	XTX TOPCO LTD	0.16%	37.79K	13.57K	2.05K	+5.72%
Jun 30, 2025	NORTHERN TRUST CORP	0.08%	18.41K	6.61K	0	0
Jun 30, 2025	ACADIAN ASSET MANAGEMENT LLC	0.07%	16.43K	4K	-1.4K	-7.87%
Jun 30, 2025	ORBIMED ADVISORS LLC	13.39%	3.1M	1.11M	0	0
Jun 30, 2025	FMR LLC	4.9%	1.13M	407.1K	0	0
Jun 30, 2025	POINT72 ASSET MANAGEMENT, L.P.	3.53%	816.92K	293.28K	-62.01K	-7.06%
Jun 30, 2025	72 INVESTMENT HOLDINGS, LLC	2.38%	549.98K	197.44K	0	0
Jun 30, 2025	RENAISSANCE TECHNOLOGIES LLC	0.2%	47.1K	16.91K	6.9K	+17.16%
Jun 30, 2025	GTS SECURITIES LLC	0.2%	45.16K	16.21K	45.16K	+100.00%
Jun 30, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	4.74K	1.7K	-20	-0.42%
Jun 30, 2025	BML CAPITAL MANAGEMENT, LLC	4.77%	1.1M	396.12K	0	0
Jun 30, 2025	BANK OF AMERICA CORP /DE/	0%	150	54	-891.38K	-99.98%
Jun 30, 2025	BNP PARIBAS ARBITRAGE, SNC	0%	121	43	0	0
Jun 30, 2025	MILLENNIUM MANAGEMENT LLC	0%	0	-	-38.86K	-100.00%
Jun 30, 2025	NORDWAND ADVISORS, LLC	0%	0	-	-20K	-100.00%
Jun 30, 2025	GEODE CAPITAL MANAGEMENT, LLC	0.56%	130.08K	46.7K	-6.7K	-4.90%
Jun 30, 2025	DELTEC ASSET MANAGEMENT LLC	0.46%	106.06K	38.07K	106.06K	+100.00%
Jun 30, 2025	VANGUARD GROUP INC	0.36%	83.93K	30.13K	-431.16K	-83.71%
Jun 30, 2025	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.34%	79.31K	28.47K	54K	+213.40%
Jun 30, 2025	HRT FINANCIAL LP	0.24%	55.86K	20K	43.78K	+362.29%
Jun 30, 2025	UBS GROUP AG	0%	71	25	0	0
Jun 30, 2025	PFM HEALTH SCIENCES, LP	0%	0	-	-932.35K	-100.00%
Mar 31, 2025	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.11%	25.31K	10.38K	-42.02K	-62.41%
Mar 31, 2025	NORDWAND ADVISORS, LLC	0.09%	20K	8.2K	20K	+100.00%
Mar 31, 2025	MILLENNIUM MANAGEMENT LLC	0.17%	38.86K	15.93K	-34.89K	-47.31%
Mar 31, 2025	NORTHERN TRUST CORP	0.08%	18.41K	7.55K	0	0
Mar 31, 2025	RENAISSANCE TECHNOLOGIES LLC	0.17%	40.2K	16.48K	16.3K	+68.20%
Mar 31, 2025	XTX TOPCO LTD	0.15%	35.74K	14.65K	23.98K	+203.95%
Mar 31, 2025	CITIGROUP INC	0%	0	-	-61.41K	-100.00%
Mar 31, 2025	GOLDMAN SACHS GROUP INC	0%	0	-	-20.52K	-100.00%
Mar 31, 2025	BNP PARIBAS ARBITRAGE, SNC	0%	121	50	-15.12K	-99.21%
Mar 31, 2025	UBS GROUP AG	0%	71	29	0	0
Mar 31, 2025	BARCLAYS PLC	0%	0	-	-114.06K	-100.00%
Mar 31, 2025	FIL LTD	0%	0	-	-192.66K	-100.00%
Mar 31, 2025	SECTORAL ASSET MANAGEMENT INC	0%	0	-	-517.65K	-100.00%
Mar 31, 2025	ORBIMED ADVISORS LLC	13.39%	3.1M	1.27M	0	0
Mar 31, 2025	FMR LLC	4.9%	1.13M	464.94K	-50.06K	-4.23%
Mar 31, 2025	JPMORGAN CHASE & CO	0%	196	81	-3	-1.51%
Mar 31, 2025	CITADEL ADVISORS LLC	0%	0	-	-689.21K	-100.00%
Mar 31, 2025	VIRTU FINANCIAL LLC	0%	0	-	-14.81K	-100.00%
Mar 31, 2025	BML CAPITAL MANAGEMENT, LLC	4.77%	1.1M	452.39K	1.1M	+100.00%
Mar 31, 2025	PFM HEALTH SCIENCES, LP	4.03%	932.35K	382.26K	0	0
Mar 31, 2025	TAKEDA PHARMACEUTICAL CO LTD	3.87%	895.82K	367.29K	0	0
Mar 31, 2025	ACADIAN ASSET MANAGEMENT LLC	0.08%	17.83K	6K	0	0
Mar 31, 2025	HRT FINANCIAL LP	0.05%	12.08K	4K	12.08K	+100.00%
Mar 31, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	4.76K	1.95K	-45	-0.94%
Mar 31, 2025	BANK OF AMERICA CORP /DE/	3.85%	891.53K	365.53K	5	0.00%
Mar 31, 2025	POINT72 ASSET MANAGEMENT, L.P.	3.8%	878.93K	360.36K	-55.43K	-5.93%
Mar 31, 2025	72 INVESTMENT HOLDINGS, LLC	2.38%	549.98K	225.49K	0	0
Mar 31, 2025	VANGUARD GROUP INC	2.23%	515.09K	211.19K	-63.91K	-11.04%
Mar 31, 2025	GEODE CAPITAL MANAGEMENT, LLC	0.59%	136.78K	56.09K	-1.88K	-1.36%
Mar 31, 2025	BLACKROCK, INC.	0.18%	42.4K	17.38K	-792	-1.83%

Insiders

Among the TSBX insiders holding of 7.7% of the stake in company, ORBIMED ADVISORS LLC, , holds the largest shares of 3.1M. VERSANT VENTURES V, LLC, 10 percent owner, is the second largest TSBX insider with ownership of 82.01K shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
ORBIMED ADVISORS LLC		3.1M
VERSANT VENTURES V, LLC	10 percent owner	82.01K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jul 25, 2023	VERSANT VENTURES V, LLC	PURCHASE	12.00	5.94K	71.27K	82.01K
Jul 20, 2023	ORBIMED ADVISORS LLC	PURCHASE	12.00	416.67K	5M	3.1M

TSBX Stock Ownership Breakdown